Merck & Co. Inc. buy Guggenheim
Start price
06.11.24
/
50%
€94.60
Target price
06.11.25
€121.00
Performance (%)
-21.04%
End price
07.11.25
€74.70
Summary
This prediction ended on 07.11.25 with a price of €74.70. The price of Merck & Co. Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.04%. Guggenheim has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €1.58 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 6.579% | 6.579% | -6.702% |
| iShares Core DAX® | 0.765% | 4.791% | 21.634% |
| iShares Nasdaq 100 | 1.418% | 3.133% | 5.422% |
| iShares Nikkei 225® | 0.658% | 0.972% | 15.333% |
| iShares S&P 500 | 1.310% | 2.279% | 3.125% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $137.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Merck & Co. Inc.
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€68.70
17.04.25
17.04.25
€101.20
17.04.26
17.04.26
29.69%
23.12.25
23.12.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24